Version history

{
  "session_id": "sess_SDA-2026-04-15-gap-pubmed-20260411-075338-35f913fb_20260416-034701",
  "round_number": 1,
  "agent_persona": "persona-theorist",
  "agent_backend": "minimax/MiniMax-M2.7",
  "action": "propose",
  "content": "\n\n# Mechanistic Hypotheses: HDAC9 Overexpression in Alzheimer's Disease\n\n## Hypothesis 1: TFEB-Lyzed Autophagy Upregulation\n\n**Title**: HDAC9 Activates TFEB to Enhance Aβ Clearance\n\n**Mechanism**: HDAC9 overexpression promotes nuclear translocation of transcription factor EB (TFEB) via deacetylation of key lysosomal biogenesis genes, upregulating a coordinated gene program (including *CTSD*, *LAMP1*, *ATP6V1A*) that enhances autophagy-lysosomal degradation of extracellular Aβ deposits. This dual mechanism explains both reduced amyloid burden and improved neuronal viability.\n\n**Key Evidence**: TFEB overexpression reduces Aβ load in APP/PS1 mice (PMID: 29038251); Class IIa HDACs regulate TFEB nuclear localization in cellular stress models (PMID: 25182993).\n\n**Testable Prediction**: ChIP-seq for HDAC9 binding at the *TFEB* promoter in neurons; if HDAC9 overexpression increases TFEB target gene expression without direct promoter binding, the hypothesis is falsified—autophagy enhancement must occur via indirect mechanisms.\n\n**Target Gene/Protein**: TFEB (transcription factor EB)\n\n---\n\n## Hypothesis 2: Microglial HDAC9 Represses NF-κB Pro-inflammatory Gene Program\n\n**Title**: HDAC9 Represses Microglial NF-κB to Reduce Neurotoxic Aβ Production\n\n**Mechanism**: Neuronal and/or microglial HDAC9 forms a repressive complex with HDAC3 at NF-κB target gene promoters (including *IL1B*, *TNF*, *CCL2*), dampening chronic neuroinflammation that drives Aβ production from neurons and microglial phagocytic dysfunction. Reduced inflammatory signaling restores Aβ clearance capacity and prevents synaptic spine loss.\n\n**Key Evidence**: Neuronal HDAC9 regulates neuroinflammatory responses (PMID: 31935184); HDAC3/NCoR complexes repress NF-κB-dependent transcription in macrophages (PMID: 24703648).\n\n**Testable Prediction**: Perform RNA-seq from cortical tissue of HDAC9-overexpressing vs. control AD mice; if pro-inflammatory genes are NOT downregulated (fold-change < -0.3), the NF-κB repression model is invalidated.\n\n**Target Gene/Protein**: NF-κB (p65/RELA) transcription complex\n\n---\n\n## Hypothesis 3: HDAC9-Mediated Synaptic Vesicle Gene Upregulation\n\n**Title**: HDAC9 Epigenetically Upregulates Presynaptic Vesicle Genes\n\n**Mechanism**: HDAC9 paradoxically activates transcription of synaptic vesicle cycle genes (*SYN1*, *SYP*, *VAMP2*, *SNAP25*) by displacing HDAC3 from shared gene promoters, increasing histone H3K27 acetylation at these loci. Enhanced expression of synaptic proteins stabilizes presynaptic terminals against Aβ-induced dysfunction, improving neurotransmission independent of amyloid reduction.\n\n**Key Evidence**: HDAC9 can function as a transcriptional activator in specific contexts (PMID: 26242209); synaptic vesicle genes are dysregulated in AD and correlate with cognitive decline (PMID: 33062438).\n\n**Testable Prediction**: siRNA knockdown of HDAC9 in neurons should reduce SYN1/VAMP2 protein levels >50% at 72h; if synaptic protein levels remain unchanged, HDAC9's transcriptional activation role at these loci is not supported.\n\n**Target Gene/Protein**: SNAP25 / Synapsin I (synaptic vesicle proteins)\n\n---\n\n## Hypothesis 4: SIRT1 Cross-Regulation of Aβ Metabolic Enzymes\n\n**Title**: HDAC9 Disinhibits SIRT1 to Suppress BACE1 Transcription\n\n**Mechanism**: HDAC9 overexpression reduces acetylation of p53, which normally transactivates *SIRT1*; elevated SIRT1 deacetylates FOXO1, preventing its nuclear export and allowing FOXO1-mediated repression of *BACE1* promoter activity. Reduced BACE1 expression decreases amyloidogenic APP processing, explaining lower Aβ42/40 ratios.\n\n**Key Evidence**: SIRT1 activation reduces BACE1 and Aβ in AD models (PMID: 23685091); FOXO1 binds BACE1 promoter to suppress its transcription (PMID: 25183010).\n\n**Testable Prediction**: Co-immunoprecipitation to test HDAC9-SIRT1 physical interaction; if SIRT1 activity does not change with HDAC9 overexpression (measured by FOXO1 deacetylation), the cross-regulation mechanism is falsified.\n\n**Target Gene/Protein**: SIRT1 (NAD+-dependent deacetylase)\n\n---\n\n## Hypothesis 5: Neuronal Metabolic Resilience via PGC-1α Mitochondrial Biogenesis\n\n**Title**: HDAC9 Promotes Mitochondrial Biogenesis via PGC-1α Deacetylation\n\n**Mechanism**: HDAC9 deacetylates and activates PGC-1α, driving transcription of mitochondrial biogenesis genes (*TFAM*, *NRF1*, *CO",
  "tokens_used": "1092"
}